ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ALNY Alnylam Pharmaceuticals Inc

241.76
0.01 (0.00%)
15 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 319.29M318.75M750.53M439.72M494.33M659.83M500.92M593.17M
Operating Income -149.81M-229.83M213.87M-116.4M-43.44M48.61M-76.91M-105.16M
Pre Tax Income -172.36M-274.21M150.74M-137.69M-63.59M-11.17M-108.66M-193.96M
Net Income -174.1M-276.02M147.75M-137.87M-65.94M-16.89M-111.57M-83.76M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -153.32M-273.99M156.21M-136.76M-49.47M-15.6M-528.36M409.72M
EBITDA -135.74M-216.65M227.2M-102.92M-29.92M63.62M-62.92M-90.99M
Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 89.91M74.91M219.75M492.85M844.29M1.04B1.83B2.25B
Operating Income -500.09M-814.67M-939.43M-828.44M-708.65M-785.07M-282.18M-176.89M
Pre Tax Income -490.87M-760.67M-885.25M-855.6M-852.14M-1.13B-433.52M-377.38M
Net Income -490.87M-761.5M-886.12M-858.28M-852.82M-1.13B-440.24M-278.16M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -4.925-7.526-7.898-7.372-7.096-9.128-3.508-2.157
EBIT -503.11M-789.94M-918.7M-782.91M-727.96M-791.28M-407.86M-183.72M
EBITDA -488.19M-801.87M-922.83M-798.24M-661.09M-740.6M-228.12M-120.22M